Pharmaceutical

CBC acquires UCB’s neurology and allergy business in China

CBC Group has completed the strategic acquisition of UCB's mature neurology and allergy business in China for $680m.

Dec 3, 2024 - 06:00
CBC acquires UCB’s neurology and allergy business in China
CBC Group has completed the strategic acquisition of UCB's mature neurology and allergy business in China for $680m.
Read the original article

Tags:

Previous Article

CHMP recommends oral peanut allergy immunotherapy treatment for toddlers  

Next Article

UQ secures funds for development of skin cancer prevention cream

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

eGenesis scoops $191m for genetically modified pig kidney transplant trial

eGenesis scoops $191m for genetically modified pig kidn...

Sep 6, 2024

STAT Virtual Event | How to Increase Diversity in Clinical Trials: Strategies & Tools

STAT Virtual Event | How to Increase Diversity in Clini...

Sep 26, 2023

Rezvilutamide by Jiangsu Hengrui Medicine for Prostate ...

Jun 5, 2023